RevitaLash® Cosmetics Launches $10 Million Initiative for Breast Cancer Research

RevitaLash® Cosmetics Commits to Fighting Breast Cancer

RevitaLash® Cosmetics, a globally recognized brand known for its innovative eyelash, eyebrow, and hair care products, is intensifying its commitment to breast cancer awareness and support with a new goal named "Road to $10 Million." As part of this initiative, the company aims to reach a milestone of $10 million in donations and non-monetary contributions dedicated to breast cancer initiatives by 2026, coinciding with its 20th anniversary.

Since its inception, RevitaLash® has proudly supported awareness, research, and patient initiatives inspired by the legacy of its late co-founder, Gayle Brinkenhoff, who fought bravely against breast cancer. The company has already achieved an impressive $9 million in contributions since 2008, signifying the substantial impact it has made in the community.

In line with its ongoing commitment called Eternally Pink®, RevitaLash® continues to contribute a portion of its sales from every product sold directly to vital breast cancer research. This year, they have committed funds towards groundbreaking studies, including the potential for a significant study focused on triple-negative breast cancer conducted at the prestigious Francis Crick Institute in London. Additionally, they are funding scalp cooling treatments to help prevent hair loss in chemotherapy patients at Ridley-Tree Cancer Center and UCLA Health in Santa Barbara, California.

The Road to $10 Million initiative's impact will reach worldwide through RevitaLash®'s collaboration with global partners. The company will match contributions from its international distribution partners to local organizations dedicated to breast cancer support, allowing for significant local engagement in the initiative.

Dariel Sidney, Vice President of Global Philanthropy and the daughter of Gayle Brinkenhoff, expressed enthusiasm about the initiative, stating, "We are excited to announce the goal of Road to $10 Million and continue our mission of supporting breast cancer research and initiatives globally. Reaching $10 million in donations and investments will not only be a milestone; it will be a celebration of what we stand for as a company."

For consumers who want to contribute to this vital cause through their purchases, additional information about RevitaLash® Cosmetics' initiatives can be found on their dedicated Eternally Pink page on their official website. The commitment to breast cancer advocacy is year-round, not just in October, showing a profound dedication to affecting change.

As a leader in developing advanced eyelash, eyebrow, and hair care products, RevitaLash®'s acclaimed collection, established in 2006, continues to thrive. Signature products such as the award-winning RevitaLash® Advanced Eyelash Conditioner and the RevitaBrow® Advanced Eyebrow Conditioner are available through physicians’ offices, spas, salons, and specialty retail locations across more than 70 countries. RevitaLash® Cosmetics remains a steadfast supporter of nonprofit breast cancer initiatives, allocating a portion of its revenue year-round to fund educational and research efforts supporting those affected by breast cancer.

More information about RevitaLash® Cosmetics and their commitment to breast cancer research can be accessed at RevitaLash's official website.